Silvercrest Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.62M | Sell |
25,960
-876
| -3% | -$123K | 0.03% | 467 |
|
|
2025
Q4 | $3.29M | Buy |
26,836
+6,299
| +31% | +$765K | 0.02% | 481 |
|
|
2025
Q3 | $2.28M | Buy |
20,537
+61
| +0.3% | +$6.93K | 0.02% | 521 |
|
|
2025
Q2 | $2.27M | Sell |
20,476
-564
| -3% | -$60K | 0.02% | 535 |
|
|
2025
Q1 | $2.36M | Buy |
21,040
+4,017
| +24% | +$414K | 0.02% | 520 |
|
|
2024
Q4 | $1.57M | Hold |
17,023
| – | – | 0.01% | 559 |
|
|
2024
Q3 | $1.43M | Hold |
17,023
| – | – | 0.01% | 530 |
|
|
2024
Q2 | $1.17M | Hold |
17,023
| – | – | 0.01% | 602 |
|
|
2024
Q1 | $1.25M | Sell |
17,023
-27
| -0.2% | -$2.08K | 0.01% | 580 |
|
|
2023
Q4 | $1.38M | Buy |
17,050
+516
| +3% | +$40.2K | 0.01% | 547 |
|
|
2023
Q3 | $1.24M | Sell |
16,534
-100
| -0.6% | -$7.69K | 0.01% | 566 |
|
|
2023
Q2 | $1.28M | Buy |
16,634
+225
| +1% | +$17.9K | 0.01% | 551 |
|
|
2023
Q1 | $1.36M | Sell |
16,409
-70
| -0.4% | -$5.8K | 0.01% | 526 |
|
|
2022
Q4 | $1.41M | Buy |
16,479
+73
| +0.4% | +$5.78K | 0.01% | 520 |
|
|
2022
Q3 | $1.01M | Sell |
16,406
-170
| -1% | -$10.7K | 0.01% | 553 |
|
|
2022
Q2 | $1.02M | Sell |
16,576
-200
| -1% | -$12.4K | 0.01% | 568 |
|
|
2022
Q1 | $997K | Sell |
16,776
-1,028
| -6% | -$65.7K | 0.01% | 596 |
|
|
2021
Q4 | $1.29M | Sell |
17,804
-622
| -3% | -$42.8K | 0.01% | 535 |
|
|
2021
Q3 | $1.29M | Sell |
18,426
-74
| -0.4% | -$5.2K | 0.01% | 535 |
|
|
2021
Q2 | $1.27M | Sell |
18,500
-250
| -1% | -$16.7K | 0.01% | 535 |
|
|
2021
Q1 | $1.21M | Sell |
18,750
-4,551
| -20% | -$293K | 0.01% | 535 |
|
|
2020
Q4 | $1.36M | Sell |
23,301
-1,294
| -5% | -$78.1K | 0.01% | 508 |
|
|
2020
Q3 | $1.55M | Sell |
24,595
-1,462
| -6% | -$101K | 0.01% | 480 |
|
|
2020
Q2 | $2M | Sell |
26,057
-440
| -2% | -$33.7K | 0.02% | 457 |
|
|
2020
Q1 | $1.98M | Sell |
26,497
-5,164
| -16% | -$357K | 0.02% | 431 |
|
|
2019
Q4 | $2.06M | Buy |
31,661
+1,250
| +4% | +$81.4K | 0.02% | 479 |
|
|
2019
Q3 | $1.93M | Sell |
30,411
-2,200
| -7% | -$144K | 0.02% | 478 |
|
|
2019
Q2 | $2.2M | Sell |
32,611
-5,080
| -13% | -$334K | 0.02% | 322 |
|
|
2019
Q1 | $2.45M | Sell |
37,691
-2,237
| -6% | -$149K | 0.02% | 295 |
|
|
2018
Q4 | $2.5M | Sell |
39,928
-220
| -0.5% | -$15.4K | 0.03% | 281 |
|
|
2018
Q3 | $3.1M | Sell |
40,148
-1,623
| -4% | -$123K | 0.03% | 275 |
|
|
2018
Q2 | $2.96M | Sell |
41,771
-8,705
| -17% | -$615K | 0.03% | 289 |
|
|
2018
Q1 | $3.81M | Buy |
50,476
+3,455
| +7% | +$275K | 0.04% | 258 |
|
|
2017
Q4 | $3.37M | Buy |
47,021
+2,516
| +6% | +$191K | 0.03% | 268 |
|
|
2017
Q3 | $3.61M | Buy |
44,505
+600
| +1% | +$45.9K | 0.04% | 257 |
|
|
2017
Q2 | $3.11M | Sell |
43,905
-302
| -0.7% | -$20.1K | 0.03% | 265 |
|
|
2017
Q1 | $3M | Sell |
44,207
-3,793
| -8% | -$267K | 0.03% | 265 |
|
|
2016
Q4 | $3.44M | Buy |
48,000
+255
| +0.5% | +$19K | 0.04% | 253 |
|
|
2016
Q3 | $3.78M | Sell |
47,745
-2,428
| -5% | -$197K | 0.05% | 247 |
|
|
2016
Q2 | $4.18M | Buy |
50,173
+580
| +1% | +$51.5K | 0.05% | 231 |
|
|
2016
Q1 | $4.56M | Sell |
49,593
-74
| -0.1% | -$6.67K | 0.06% | 208 |
|
|
2015
Q4 | $5.03M | Buy |
49,667
+3,341
| +7% | +$348K | 0.07% | 210 |
|
|
2015
Q3 | $4.55M | Buy |
46,326
+14,833
| +47% | +$1.65M | 0.07% | 201 |
|
|
2015
Q2 | $3.69M | Buy |
31,493
+8,041
| +34% | +$879K | 0.05% | 247 |
|
|
2015
Q1 | $2.3M | Buy |
23,452
+4,750
| +25% | +$482K | 0.03% | 255 |
|
|
2014
Q4 | $1.76M | Buy |
18,702
+1,900
| +11% | +$197K | 0.03% | 276 |
|
|
2014
Q3 | $1.79M | Sell |
16,802
-300
| -2% | -$29.4K | 0.03% | 277 |
|
|
2014
Q2 | $1.42M | Buy |
17,102
+1,702
| +11% | +$132K | 0.02% | 288 |
|
|
2014
Q1 | $1.09M | Sell |
15,400
-374
| -2% | -$29.3K | 0.02% | 303 |
|
|
2013
Q4 | $1.19M | Sell |
15,774
-50
| -0.3% | -$3.48K | 0.02% | 299 |
|
|
2013
Q3 | $995K | Sell |
15,824
-250
| -2% | -$14.9K | 0.02% | 305 |
|
|
2013
Q2 | $824K | Buy |
+16,074
| New | +$838K | 0.02% | 307 |
|
Other funds holding GILD
VCM
VPM
Silvercrest Asset Management's GILD Position: Q1 2026 in Review
Silvercrest Asset Management reduced its Gilead Sciences (GILD) stake by 3.3% in Q1 2026, selling an estimated $123K and leaving 25,960 shares worth $3.62M. The position accounts for 0.03% of the portfolio, ranked #467.
Silvercrest Asset Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.03M in Q4 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Silvercrest Asset Management held 25,960 shares of Gilead Sciences worth $3.62M as of Q1 2026.
- Silvercrest Asset Management sold 876 Gilead Sciences shares in Q1 2026, an estimated $123K.
- Gilead Sciences made up 0.03% of Silvercrest Asset Management's portfolio in Q1 2026, its #467 holding.
- Silvercrest Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Silvercrest Asset Management's Gilead Sciences position peaked at $5.03M in Q4 2015.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Silvercrest Asset Management's 13F filing for Q1 2026, filed 15 May 2026.